Diagnostics & Devices
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
320
NCT02857101
Calprotectin for Rapid Diagnostic Infection Spontaneous of Ascites
Phase: N/A
Role: Collaborator
Start: Feb 28, 2015
Completion: Aug 31, 2019
NCT03901690
Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study
Phase: Phase 3
Start: Aug 27, 2019
Completion: May 20, 2020
Loading map...